Julie Hambleton - Insider Trading & Ownership

Entity
Individual
Location
C/O Five Prime Therapeutics, Inc., Two Corporate Drive, South San Francisco, CA
Summary
The estimated net worth of Julie Hambleton is at least $200K dollars as of July 29, 2024. Julie Hambleton is the Director of SpringWorks Therapeutics, Inc. and owns shares of SpringWorks Therapeutics, Inc. (SWTX) stock worth about $172K. Julie Hambleton is the Director of IGM Biosciences, Inc. and owns shares of IGM Biosciences, Inc. (IGMS) stock worth about $28K.
All Insider Reports
All Insider Reports

Ownership of Julie Hambleton

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SWTX SpringWorks Therapeutics, Inc. Director $172K -$186K -51.9% Jun 3, 2024
IGMS IGM Biosciences, Inc. Director $28K -$212K -88.3% Jul 25, 2024
ERAS Erasca, Inc. Director Jun 20, 2024

Insider Transactions Reported by Julie Hambleton:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.